Silicon Valley's obsession with peptides: Inside the 'steroid Olympics'

The Enhanced Games, a sporting competition where most athletes openly use performance-enhancing drugs, has attracted significant interest from Silicon Valley investors and entrepreneurs. The event may represent a new business model at the intersection of biohacking, sports, and tech industry culture. The competition reflects a broader trend of technology leaders embracing peptides and other performance-enhancing substances.

The Enhanced Games — a sporting event explicitly designed around the use of performance-enhancing drugs — has drawn a surprising fanbase from an unlikely corner of the business world: Silicon Valley. Tech entrepreneurs and investors, long obsessed with biohacking and human optimization, have found in the so-called 'steroid Olympics' a spectacle that mirrors their own philosophy about pushing the limits of human performance.

Where sports meets biohacking

Unlike traditional athletic competitions, the Enhanced Games does not ban or test for performance-enhancing substances. A majority of the competing athletes are openly on peptides, steroids, or other pharmacological aids. For the tech industry crowd, this is not a scandal — it is a selling point. The event reframes doping not as cheating, but as technological augmentation, a framing that resonates deeply with Silicon Valley's ethos of disrupting established norms.

Peptides in particular have become a hot topic in tech circles in recent years. These short chains of amino acids, some of which are used medically and others obtained through grey-market channels, are popular among biohackers who claim they improve recovery, cognitive function, and physical performance. The Enhanced Games has brought this underground conversation into a more public arena.

A new business model in sports

Beyond the spectacle, the Enhanced Games may represent a genuinely novel business model. By openly embracing what traditional sports organizations prohibit, the competition targets an audience of performance-optimization enthusiasts willing to pay for content, supplements, and experiences tied to pushing human limits. Tech investors, comfortable with high-risk, high-reward propositions, are reportedly interested in the commercial potential of this approach.

Whether the Enhanced Games becomes a lasting institution or a niche curiosity remains to be seen. But its emergence signals that the boundaries between sports, technology, and pharmaceutical self-experimentation are blurring in ways that established sporting bodies and regulators have yet to fully reckon with.